Anika Therapeutics Launches CINGAL in the EU to Treat OA Pain

Anika Therapeutics commenced EU launch of CINGAL®, its third-generation viscosupplement, to treat osteoarthritis-related pain. The product is slated for initial availability in the Czech Republic, Germany, Hungary, Italy and Poland, to be marketed by various commercial partners.

CINGAL received CE Mark approval for the present application in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us